Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.
TriGemX Bio uses the science of gut-brain biology to create medicines that transform human health.
GT Medical Technologies develops medical technologies to improve outcomes for patients with brain tumors.
Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.
Allonnia is an environmental biotechnology company focused on metals and mining, plastics and PFAS, plus other emerging contaminants.
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Polaris Genomics identifies genomic biomarkers to support the development of psychiatric drugs and clinical tools.
Microbiome Innovation for Animal Health
NextGen Jane is a data-driven women's health company.
AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.
Canopy offers a cloud-based Practice Management solution for Accounting professionals.
Ecovative Design is a biomaterials company focused on the development of innovative materials from natural growth processes.
1Health is a health platform that connects clinicians and patients to labs.
Valsoft specializes in the acquisition and growth of vertical-market software enterprises.
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Humaneva is a healthacare research company that offers reliable clinical research data that empowers the medical community.
Trace Genomics provides genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield.
MyForest Foods grows meatless mycelium on vertical farms and supplies sustainable natural flagship products to consumers.
Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.
Keboola is a cloud platform helping clients combine, enhance and publish crucial information for internal analytics & data products.
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.
Viking Global Investors has invested in 56 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Viking Global Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 53 different industry categories.
Among tracked funding rounds, Star Therapeutics received $200.0M in a Venture - Series Unknown round. Viking Global Investors's total known invested capital is $3.0B.
Viking Global Investors's average investment size is $53.4M across its portfolio of 56 companies.
Recent Viking Global Investors portfolio additions include Star Therapeutics, Antheia, TriGemX Bio, GT Medical Technologies, Mediphage Bioceuticals. These companies were founded in 2020 or later.